In 1996 researchers injected GLP-1 directly into the brains of hungry rats, and the rodents food intake decreased by as much as 95 percent
An estimated 160,000 people in the U.S
In 2002, Eli Lilly & Company entered into a partnership with Amylin Pharmaceuticals worth $325 million for the rights to exenatide
No est recomendado para nios, mujeres embarazadas o en perodo de lactancia ni para personas bajo tratamiento antihipertensivo o antidiabtico
Digestive health and side-effect support: Products addressing common side effects (e.g., high-fibre, gut-friendly) are poised for growth
Through our established network of pharmaceutical partnerships, we are able to source the highest quality and effective medications at excellent prices that allow us to pass our savings along to our patients